[The effect of metformin on insulin receptor protein tyrosine kinase activity of HIT-T15 cell exposed to high concentration glucose and free fatty acid]

Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Sep;38(5):819-21.
[Article in Chinese]

Abstract

Objective: To study the effect of metformin on insulin receptor (IRc) protein tyrosine kinase (PTK) activity of HIT-T15 cell exposed to high glucose and free fatty acid (FFA) concentration, and to explore the mechanism of metformin (MF) improving beta cell insulin resistance.

Methods: HIT-T15 cells were incubated for 48 h in a medium containing 5.5-16.7 mmol/L glucose and 0.5 mmol/L palmitic acid respectively. The cells were re-incubated for another 24 h with or without 2.5 microg/mL MF. The PTK activities of IRc were measured by radioactive enzyme assay.

Results: The enzymatic activities of IRc PTK were significantly decreased to HIT-T15 cells having the exposure to high glucose or high FFA concentration, when compared to control [(52.5 +/- 18.6) or (54.6 +/- 14.0) vs. (119.4 +/- 29.1) pmol/(min x microg), P < 0.01 respectively. The enzymatic activities of IRc PTK in HIT-T15 cells reincubated with 2.5 microg/mL MF for an additional 24 h were significantly increased vs MF free group [(113.0 +/- 29.8) vs. (52.5 +/- 18.6) pmol/(min x microg), x 98.6 +/- 26.1) vs. (54.6 +/- 14.0) pmol/(min x microg), P < 0.01 respectively], and were no significant difference in comparison with control group (P > 0.05).

Conclusion: The enzymatic activities of IRc PTK are significantly decreased in HIT-T15 cells chronically exposed to elevated glucose or free fatty acids levels. Metformin can restore approximately normal enzymatic activities of PTK of HIT-T15 cells, of which the PTK activities have been impaired by chronic exposure to high glucose or free fatty acids levels.

Publication types

  • English Abstract

MeSH terms

  • Animals
  • Cell Line
  • Cricetinae
  • Fatty Acids, Nonesterified / metabolism*
  • Glucose / metabolism*
  • Hypoglycemic Agents / pharmacology
  • Insulin Resistance
  • Insulin-Secreting Cells / drug effects*
  • Insulin-Secreting Cells / enzymology
  • Metformin / pharmacology*
  • Protein-Tyrosine Kinases / metabolism*
  • Receptor, Insulin / metabolism*

Substances

  • Fatty Acids, Nonesterified
  • Hypoglycemic Agents
  • Metformin
  • Protein-Tyrosine Kinases
  • Receptor, Insulin
  • Glucose